We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · June 08, 2021

Change in NT-proBNP at 1 Year Predicts Mortality in Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy

Heart (British Cardiac Society)


Additional Info

Disclosure statements are available on the authors' profiles:

Heart (British Cardiac Society)
Change in N-Terminal Pro-B-Type Natriuretic Peptide at 1 Year Predicts Mortality in Wild-Type Transthyretin Amyloid Cardiomyopathy
Heart 2021 May 14;[EPub Ahead of Print], S Law, A Petrie, L Chacko, OC Cohen, S Ravichandran, JA Gilbertson, D Rowczenio, AD Wechalekar, A Martinez-Naharro, HJ Lachmann, CJ Whelan, DF Hutt, PN Hawkins, M Fontana, JD Gillmore

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading